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Abstract
Leg ulcer is a disabling complication in patients with sickle cell anemia (SCA) but the exact pathophysiological
mechanisms are unknown. The aim of this study was to identify the hematological and hemorheological alterations
associated with recurrent leg ulcers. Sixty-two SCA patients who never experienced leg ulcers (ULC-) and 13 SCA
patients with a positive history of recurrent leg ulcers (ULC+) - but with no leg ulcers at the time of the study – were
recruited. All patients were in steady state condition. Blood was sampled to perform hematological, biochemical
(hemolytic markers) and hemorheological analyses (blood viscosity, red blood cell deformability and aggregation
properties). The hematocrit-to-viscosity ratio (HVR), which reflects the red blood cell oxygen transport efficiency, was
calculated for each subject. Patients from the ULC+ group were older than patients from the ULC- group. Anemia
(red blood cell count, hematocrit and hemoglobin levels) was more pronounced in the ULC+ group. Lactate
dehydrogenase level was higher in the ULC+ group than in the ULC- group. Neither blood viscosity, nor RBC
aggregation properties differed between the two groups. HVR was lower and RBC deformability tended to be
reduced in the ULC+ group. Our study confirmed increased hemolytic rate and anemia in SCA patients with leg
ulcers recurrence. Furthermore, our data suggest that although systemic blood viscosity is not a major factor involved
in the pathophysiology of this complication, decreased red blood cell oxygen transport efficiency (i.e., low hematocrit/
viscosity ratio) may play a role.
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Introduction
Leg ulcers have been previously reported in 25-65% of adult
sickle cell patients in Jamaica [1,2] but the incidence is much
lower (2-2.5%) in North America [2,3]. Leg ulcers are often
refractory to treatment and are prone to recurrence [1,2]. While
the exact causes of recurrent leg ulcers are unknown [4–7],
several studies support a role of hemolysis. Nolan et al [7]
shown that patients with sickle cell anemia (SCA) and leg
ulcers had lower hemoglobin level and higher levels of lactate
dehydrogenase (LDH), bilirubin, aspartate transaminase and
reticulocyte counts than SCA patients without leg ulcers.
Similar observation was made by Taylor et al [8] who observed
higher frequency of patients with a positive history of leg ulcers
in the top quartile of serum LDH level in the NIH database and
the Cooperative Study of Sickle Cell Disease database
(CSSD). Cumming et al [9], in The Jamaican Cohort Study,
reported that high serum LDH, with low socio-economic status
and venous incompetence, were strong predictors of chronic
leg ulceration in SCA patients. Indeed, leg ulcer is considered
to belong to the hemolytic-endothelial dysfunction sub-
phenotype [10], with chronic hemolysis being responsible for
the decrease of nitric oxide (NO) bio-availability leading to
impaired vasomotor tone and promoting the development of
vasculopathy.
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Recently, a study reported that SCA patients with leg ulcers
exhibited greater blood viscosity that patients without this
complication, despite a lower hematocrit in the former group
[4]. The authors hypothesized that the higher blood viscosity
probably compromise tissue oxygenation and thus promote the
development of leg ulcers [4]. Their hypothesis was partly
supported by the lower hematocrit-to-viscosity ratio - an index
which reflects the red blood cell oxygen transport efficiency [11]
- in patients with leg ulcers. However, this finding is surprising
since the greater hemolytic rate and the more pronounced
anemia in SCA patients with leg ulcers should lead to a lower
blood viscosity. To address this paradox, we compared the
hematological, biochemical and hemorheological profiles of
SCA patients with recurrent leg ulcers to patients who never
had leg ulcers. Patients characterized by recurrent leg ulcers
did not have this complication at the time of the study to avoid
any acute inflammatory effects on blood rheology [12]. The aim
of this study was to identify the hemorheological alterations
associated with recurrent leg ulcers.
Material and Methods
Patients
The study is a part of the “Sickle cell hemorheology study”
[13,14], which took place between May 2010 and December
2011. Ninety-seven adults with SCA regularly followed by the
Sickle Cell Center at the Academic Hospital of Pointe-à-Pitre
(Guadeloupe, French West Indies) were included in this study.
However, 19 SCA patients were excluded from the analysis
because they were under hydroxyurea therapy, which is known
to modulate blood rheology and hematological parameters
[14,15]. Three other SCA patients were also excluded because
they had leg ulcers at the time of the study. Thus, 62 SCA
patients who never experienced leg ulcers (ULC-) and 13 SCA
patients with a positive history of recurrent leg ulcers (ULC+) -
but with no leg ulcers at the time of the study - were included in
the analyses. Age at which the first leg ulcer occurred, the
mean duration and the mean frequency of leg ulcers episodes
are given in the Table 1. All patients were in steady-state
condition at the time of the study: no blood transfusions in the
previous three months and absence of acute episodes
(infection, vaso-occlusive crisis (VOC), acute chest syndrome
(ACS), stroke, priapism) at least two months before inclusion
into the study.
All patients were informed about the purpose and procedures
of the study, and gave their written consent. The study was
conducted in accordance with the guidelines set by the
Declaration of Helsinki and was approved by the Regional
Ethics Committee (CPP Sud/Ouest Outre Mer III, Bordeaux,
France, registration number: 2010-A00244-35).
Genetic parameters
SCA diagnosis was made by isoelectrofocusing (Multiphor
II™ System, GE HEALTH CARE, Buck, UK), citrate agar
electrophoresis, and cation-exchange high performance liquid
chromatography (VARIANT™, Bio-Rad Laboratories, Hercules,
CA, USA), and was confirmed by DNA studies [16].
Polymerase Chain Reaction (Gap-PCR) was used to detect 6
common alpha-thalassemia deletions [17,18].
Biological parameters
Blood samples were drawn after a 12-hrs overnight fasting,
between 8:00 a.m. and 10:00 a.m., and were immediately used
for analyses.
Hemoglobin concentration (Hb), hematocrit (Hct), mean
corpuscular volume (MCV), mean corpuscular hemoglobin
(MCH), reticulocytes (RET), red blood cell (RBC), platelet
(PLT) and white blood cell (WBC) counts were determined
using hematology analyzer (Max M-Retic, Coulter, USA).
Measurements of hemolytic markers (bilirubin, BIL; lactate
dehydrogenase, LDH; aspartate aminotransferase, AST) and
C-reactive protein (CRP) level were performed using standard
biochemistry. A principal component analysis was used to
derive a hemolytic component from the 4 hemolytic markers
measured (i.e. BIL, LDH, AST and reticulocytes expressed in
percentage). This standard statistical data reduction approach
uses conventional clinical measurements to explain the
Table 1. Comparison of the general characteristics and
hematological parameters between SCA patients without
(ULC-) and with (ULC+) leg ulcers.
 ULC- ULC+
Sex (M/F) 26/36 4/9
Age (years) 31.8 ± 12.3 41.9 ± 12.6**
Age at which the first leg ulcer occurred (years)$ - 26.2 ± 10.5
Mean duration of leg ulcer episodes (months)  6.5 ± 10.0
Frequency of leg ulcers episodes (per year)  0.7 ± 0.4
Height (cm) 169 ± 9 171 ± 8
Weight (kg) 61.8 ± 9.9 61.0 ± 11.0
Body mass index (kg/m2) 21.6 ± 3.4 21.0 ± 4.3
HbF (%) 8.2 ± 5.6 9.4 ± 7.3
alpha-thalassemia (%) 45.2 46.2
RBC (1012/L) 3.0 ± 0.6 2.6 ± 0.5*
WBC (109/L) 9.9 ± 2.3 10.4 ± 2.9
PLT (109/L) 414 ± 132 373 ± 115
Hb (g/dL) 8.6 ± 1.2 7.8 ± 1.4*
Hct (%) 24.2 ± 3.5 21.7 ± 3.8*
MCV (fl) 82.7 ± 8.9 84.4 ± 6.5
MCHC (pg) 29.5 ± 3.4 30.1 ± 3.8
RET (%) 8.3 ± 3.1 8.6 ± 3.2
BIL mM 58.8 ± 46.0 51.3 ± 21.1
LDH (UI/L) 491 ± 156 591 ± 147*
AST (UI/L) 37 ± 12 43 ± 15
Hemolytic component (relative unit) -0.10 ± 0.87 0.37 ± 0.97
CRP (mg/L) 6.45 ± 6.17 7.25 ± 6.94
Values represent mean ± SD. HbF, percent of foetal hemoglobin; RBC, red blood
cell; WBC, white blood cell; PLT, platelet; Hb, hemoglobin concentration; Hct,
hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin;
RET, reticulocytes; BIL, bilirubin; LDH, lactate dehydrogenase; AST, aspartate
aminotransferase; CRP, C-reactive protein level. Significant difference (*p < 0.05;
**p < 0.01). $No difference with the mean age of the ULC- group.
doi: 10.1371/journal.pone.0079680.t001
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maximum-shared variance among these indirect measures of
hemolysis [19]. The hemolytic component has recently been
demonstrated to reflect intravascular hemolysis assessed by
measurements of the cell-free plasma hemoglobin [19].
Blood viscosity was measured after complete oxygenation of
the blood, at native Hct, at 25°C and at a shear rate of 225 s−1
using a cone/plate viscometer (Brookfield DVII+ with CPE40
spindle, Brookfield Engineering Labs, Natick, MA) [20]. The
hematocrit-to-viscosity ratio (HVR) was calculated as follows:
Hct/blood viscosity at 225 s-1, with Hct determined by
microcentrifugation techniques [11]. HVR reflects a balance
between blood oxygen carrying capacity (i.e., hematocrit) and
blood flow resistance (i.e., blood viscosity): the highest the
HVR, the greatest the RBC oxygen transport effectiveness
[11,21,22].. RBC deformability was determined at 37°C at 30
Pa by laser diffraction analysis (ecktacytometry), using the
Laser-assisted Optical Rotational Cell Analyzer (LORCA, RR
Mechatronics, Hoorn, The Netherlands). RBC aggregation was
determined at 37°C via syllectometry, (i.e., laser backscatter
versus time, using the LORCA) after adjustment of the Hct to
40%, and was reported as the aggregation index (AI). The RBC
disaggregation threshold (Disth), i.e., the minimal shear rate
needed to prevent RBC aggregation or to break down existing
RBC aggregates, was determined using a re-iteration
procedure. The guidelines for international standardization in
blood rheology techniques/measurements were strictly followed
[20].
Statistical analysis
Results are presented as means ± SD. Unpaired Student’s t-
test and chi-square test were used for continuous covariates
and for categorical covariates, respectively, to compare
biological parameters between the ULC- and ULC+ groups.
Principal component analysis was used to derive the hemolytic
component. Significance level was defined as p < 0.05.
Analyses were conducted using SPSS (v. 20, IBM SPSS
Statistics, Chicago, IL).
Results and Discussion
General, hematological and biochemical parameters
(Table 1)
ULC+ patients were older than ULC- patients (p < 0.01), but
the age at which the first leg ulcer occurred in the ULC+ group
was not different from the mean age of the ULC- group. A
predominance of females was observed in the ULC+ group,
which contrasts with a recent study performed by Delaney et al
[3] on a larger cohort. RBC count, Hb and Hct levels were
lower in the ULC+ group compared to the ULC- group (p <
0.05). As already reported [7–9,23], this greater anemia was
attributed to the greater hemolytic rate observed in the ULC+
group: although RET and BIL were not different between the
two groups, AST tended to be increased (p < 0.1), LDH was
higher (p < 0.05) and the hemolytic component tended to be
higher (p < 0.1) in the ULC+ group compared to the ULC-
group. The higher hemolytic rate is expected to decrease the
amount of circulating NO and promote endothelial dysfunction
[10]. Bowers et al [4] found increased level of sICAM-1 in SCA
patients with leg ulcers, which supports increased activated
state of the endothelial cells. The reason for the increased
hemolytic rate and lower Hb level in SCA patients with a
positive history of leg ulcers has been attributed to the lower
frequency of alpha-thalassemia [23]. While we previously
showed in our cohort of SCA adults that those with alpha-
thalassemia had lower hemolytic rate and increased Hb level
[14,24], we did not detect any difference in the frequency of
alpha-thalassemia between ULC+ and ULC- patients, which is
in agreement with another study [25]. These apparently
conflicting results could be due to the small magnitude of the
effect of alpha-thalassemia on leg ulcers [25].
Hemorheological parameters (Table 2)
Despite lower Hb and Hct levels observed in the ULC+
group, we detected no difference in blood viscosity between
the two groups. This result may seem surprising but blood
viscosity at high shear rate is also widely influenced by RBC
deformability: poor deformable RBCs cannot easily align into
the direction of the flow, which ultimately increases the flow
resistance [26]. We detected a tendency for a lower RBC
deformability in the ULC+ patients compared to the ULC- group
(p < 0.1). It is therefore tempting to hypothesize that blood
viscosity was not different between the two groups because
RBC deformability of the ULC+ group was reduced by 16%
compared to that of ULC- patients. The mechanism of the RBC
deformability reduction in ULC+ patients remains unknown but
this finding is in agreement with the results recently reported by
Bartolucci et al [27] who demonstrated that the percent of
dense dehydrated red blood cells (i.e. the more rigid) was
greater in patients with leg ulcers compared to those without. In
addition, the authors [27] reported significant relationships
between the percent of dense RBCs and Hb level (r = -0.40; p
< 0.001) and different hemolytic markers: LDH (r = 0.43; p <
0.001) and bilirubin (r = 0.30; p < 0.001). We found a significant
negative relationship between the hemolytic component and
RBC deformability (r = - 0.60; p < 0.001). This finding suggests
that a lower RBC deformability is associated with higher rate of
hemolysis: probably because rigid RBCs are more fragile.
Surprisingly, Bowers et al [4] found higher blood viscosity in
patients with leg ulcers despite lower Hb and Hct levels
compared to patients without leg ulcers. However, the patients
Table 2. Comparison of hemorheological parameters
between SCA patients without (ULC-) and with (ULC+) leg
ulcers.
 ULC- ULC+
Blood viscosity (mPa.s-1) 6.1 ± 1.1 6.1 ± 0.9
HVR (a.u.) 4.1 ± 0.8 3.6 ± 0.5*
RBC deformability at 30 Pa 0.37 ± 0.09 0.32 ± 0.09
RBC aggregation index (%) 52 ± 10 55 ± 9
RBC disaggregation threshold (s-1) 289 ± 145 297 ± 147
Values represent mean ± SD. HVR, hematocrit-to-viscosity ratio; RBC, red blood
cell. Significant difference (*p < 0.05).
doi: 10.1371/journal.pone.0079680.t002
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tested by Bowers et al [4] had ongoing leg ulcers at the time of
the experiment, in contrast with our study, and local factors
such as inflammation [28] could have affected blood viscosity.
Nevertheless, in agreement with Bowers et al [4], the ULC+
group had a lower HVR than the ULC- group (p < 0.05).
Because tissue oxygenation may depend on HVR [11,29], a
low HVR could participate to the pathophysiology of this
recurrent complication.
In conclusion, our study confirms that patient with recurrent
ulcers have a higher LDH and lower Hb than patients who
never had ulcers. Furthermore, our data suggest that although
systemic blood viscosity is not a major factor involved in the
pathophysiology of this complication, decreased red blood cell
oxygen transport efficiency (i.e., low hematocrit/viscosity ratio)
may play a role. This study is a post-study analysis deriving
from previous data [13,14]. The limited sample size and the
fact that patients from the ULC+ group were older than patients
from the ULC- group represent a major limitation. For example,
it is unknown whether age may affect hemorheological
parameters in SCA patients. Indeed, to strengthen our data,
future studies will have to match patients with and without leg
ulcers on age.
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